Day One Biopharma jumps after Servier announces $2.5 billion acquisition
06/03/2026 14:15
** Shares of drugmaker Day One Biopharmaceuticals DAWN.O surge 65.9% to $21.20 premarket ** French drugmaker Servier said it will buy co for about $2.5 billion ** Servier to pay $21.50 per share of DAWN in cash, which represents a premium of 68% to stock's last close ** As of last close, DAWN up 37.1% YTD (Reporting by Puyaan Singh) ((Puyaan.Singh@thomsonreuters.com;))